Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

Explore new therapeutic targets for leukaemia treatment discovered by researchers in Japan, focusing on acute myeloid ...

Explore the exciting advancements in organoids with the successful growth of liver tissue that includes internal blood ...

Explore the link between α2,6-sialyltransferase-I and Alzheimer's disease progression. Understand the new findings on ...

A team of scientists at POSTECH have successfully developed a three-dimensional brain model that closely replicates the human brain’s structure and function. Their groundbreaking study was published ...

Under the agreement, Chiesi obtains a worldwide, royalty-bearing license to develop and commercialise two BBB-penetrant ERTs from Key2Brain. These therapies are built on a prior research collaboration ...

Fauna Bio has announced the launch of Fauna Brain, a new AI platform designed to accelerate drug target discovery and streamline early-stage research and development. Building on the company’s ...

This episode, ‘ Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials,’ will explore the challenges and successes of moving promising drug candidates from preclinical ...

DenovAI, an AI-first biotechnology company, has published a new study in Molecular Systems Biology demonstrating the power of its novel de novo protein design tool. The study introduces an advanced AI ...

A team at Southern Medical University has developed a novel self-propelled ferroptosis nanoinducer that significantly improves tumour tissue penetration – one of the biggest hurdles facing ...

By working with collaborators from Weill Cornell Medicine, Houston Methodist Cancer Center, the Hospital for Sick Children in Toronto, and the National Cancer Institute, Jiang hopes to accelerate the ...